van Baak M A, Jennen W, Muijtjens A, Verstappen F T
Int J Sports Med. 1985 Dec;6(6):347-52. doi: 10.1055/s-2008-1025869.
The effects of different dosages of the beta 1-adrenoceptor blocker metoprolol and of acute and chronic administration of this beta-blocker during physical exercise were compared in healthy normotensive subjects. Placebo, 0.15 mg/kg, and 0.30 mg/kg metoprolol were administered intravenously 10 min before a progressive bicycle ergometer test up to exhaustion. Thereafter, subjects were treated for 4 weeks with placebo or slow-release metoprolol (1 X 200 mg/day). At the end of each 4th week of treatment, a maximal exercise test was performed. Heart rate, ventilation, oxygen consumption, and plasma concentrations of free fatty acids, glucose, and lactate were determined at rest and during exercise. After the low (0.15 mg/kg) i.v. dose, the heart rate during maximal exercise was reduced from 189 +/- 2 to 155 +/- 2 bts/min (P less than 0.001). This reduction was significantly smaller than that after the high (0.30 mg/kg) i.v. dose (177 +/- 3 to 137 +/- 4 bts/min, P less than 0.001) and during chronic treatment (176 +/- 3 to 132 +/- 2 bts/min, P less than 0.001). The difference between the high i.v. dose and chronic treatment was not significant. After the low i.v. dose, the heart rate was the only variable affected. After the high i.v. dose, the heart rate, exercise time, maximal oxygen uptake, and plasma glucose and free fatty acid concentration during maximal exercise were reduced, and maximal lactate concentration tended to be lower. During submaximal exercise, no significant differences between placebo or beta-blocker administration were found, except for heart rate, which was reduced after beta-blockade.(ABSTRACT TRUNCATED AT 250 WORDS)
在健康的血压正常受试者中,比较了不同剂量的β1肾上腺素能受体阻滞剂美托洛尔以及在体育锻炼期间急性和慢性给予该β受体阻滞剂的效果。在进行递增式自行车测力计测试直至力竭前10分钟,静脉注射安慰剂、0.15mg/kg和美托洛尔0.30mg/kg。此后,受试者接受安慰剂或缓释美托洛尔(每日1次,每次200mg)治疗4周。在每个治疗周期的第4周结束时,进行一次最大运动测试。在静息状态和运动期间,测定心率、通气量、耗氧量以及游离脂肪酸、葡萄糖和乳酸的血浆浓度。静脉注射低剂量(0.15mg/kg)后,最大运动时的心率从189±2次/分钟降至155±2次/分钟(P<0.001)。这种降低显著小于静脉注射高剂量(0.30mg/kg)后(从177±3次/分钟降至137±4次/分钟,P<0.001)以及慢性治疗期间(从176±3次/分钟降至132±2次/分钟,P<0.001)。静脉注射高剂量与慢性治疗之间的差异不显著。静脉注射低剂量后,心率是唯一受影响的变量。静脉注射高剂量后,最大运动时的心率、运动时间、最大摄氧量以及血浆葡萄糖和游离脂肪酸浓度降低,最大乳酸浓度有降低趋势。在次最大运动期间,除了心率在β受体阻滞剂给药后降低外,安慰剂或β受体阻滞剂给药之间未发现显著差异。(摘要截断于250字)